EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

What Is the Current State of Stem Cell Therapy in Diabetes?

Estera Bakinowska, Wojciech Jerzy Biniek, Kajetan Kiełbowski iD, Kamil Dyrka iD, Konrad Szewczyk iD, Hanna Ostałowska, Zuzanna Leciej iD, Andrzej Pawlik iD

Cells · 15.05.2026 · 15 (10) · 907

DOI: 10.3390/cells15100907 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 15.05.2026. Verfasst von Estera Bakinowska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Stem Cell Transplantation, Insulin-Secreting Cells, Mesenchymal Stem Cells. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a chronic and progressive metabolic disorder associated with abnormal blood glucose levels. The term involves several diseases with different pathophysiology mechanisms and treatment strategies. Stem cell-based treatments represent an emerging strategy for patients with diabetes mellitus with severe pancreatic insufficiency and poor glycemic control. Over the last 20 years, researchers have investigated mesenchymal stem cell infusion and the transplantation of stem cell-derived β cells and islet tissues. This review aims to comprehensively discuss the latest advances in the field of stem cell use in diabetes, including clinical studies and preclinical experiments aiming at improving the efficacy and safety of stem cell use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusStem Cell TransplantationInsulin-Secreting CellsMesenchymal Stem CellsIslets of Langerhans TransplantationCell DifferentiationHumansAnimals

Stichwörter der Autor:innen

diabetes mellitusinduced pluripotent stem cellsmesenchymal stem cellspancreatic differentiationstem cells

Autor:innen und Institutionen

  • Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Doctoral School, Poznan University of Medical Sciences, 60-812 Poznan, Poland.
  • Department of Pediatric Endocrinology and Rheumatology, Institute of Pediatrics, University of Medical Sciences, 60-572 Poznan, Poland.

ORCID-Profile: Kajetan Kiełbowski, Kamil Dyrka, Konrad Szewczyk, Zuzanna Leciej, Andrzej Pawlik

Zitieren

APA

Bakinowska, E., Biniek, W. J., Kiełbowski, K., Dyrka, K., Szewczyk, K., Ostałowska, H., Leciej, Z., & Pawlik, A. (2026). What Is the Current State of Stem Cell Therapy in Diabetes?. Cells, 15(10), 907. https://doi.org/10.3390/cells15100907

Vancouver

Bakinowska E, Biniek WJ, Kiełbowski K, Dyrka K, Szewczyk K, Ostałowska H, et al. What Is the Current State of Stem Cell Therapy in Diabetes?. Cells. 2026;15(10):907. doi:10.3390/cells15100907

BibTeX
@article{Bakinowska2026,
  author = {Bakinowska, Estera and Biniek, Wojciech Jerzy and Kiełbowski, Kajetan and Dyrka, Kamil and Szewczyk, Konrad and Ostałowska, Hanna and Leciej, Zuzanna and Pawlik, Andrzej},
  title = {What Is the Current State of Stem Cell Therapy in Diabetes?},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {907},
  doi = {10.3390/cells15100907}
}
Kostenlos starten →